StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
KRSAKorsana Biosciences, Inc.
stockpulse.co.kr
Nasdaq
$31.31▼ 0.56%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

7
  • 2d agoAfter-hours26.10.23 05:06
    144Ownership#●●●#●●●

    Korsana Biosciences, Inc.

    Korsana Biosciences insider Michael J. Higgins has filed a Form 144 to report the proposed sale of company securities. This filing serves as a standard notification of an insider's intent to dispose of shares.…more

    $31.31-0.56%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.15After-hours26.10.16 05:30
    SCHEDULE 13G/AOwnership

    Korsana Biosciences, Inc.

    J. Wood Capital Advisors LLC has filed a SCHEDULE 13G/A regarding its beneficial ownership in Korsana Biosciences, Inc. This filing reflects an update to the reporting entity's equity position in the company.…more

    $31.31-0.56%vs prev close
    View filingShare
  • 10.15After-hours26.10.16 05:15
    DEF 14AOther

    Korsana Biosciences, Inc.

    Korsana Biosciences will hold a special meeting of shareholders on November 13, 2026, to resubmit the proposal to redomesticate the company from Massachusetts to the Cayman Islands. The proposal previously failed to pass at the August 2026 annual meeting due to a lack of the required two-thirds affirmative vote, and the company is now seeking shareholder approval again.…more

    $31.31-0.56%vs prev close
    View filingShare

6 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.